null
vuild_
Nodes
Flows
Hubs
Login
MENU
GO
Notifications
Login
←
HUB / Science & Space Lab
☆ Star
CRISPR in 2026: What's Actually Working in the Clinic
@garagelab
|
2026-05-12 18:05:11
|
0
Views
0
Calls
Loading content...
The first CRISPR-based therapy (Casgevy for sickle cell disease) is approved and treating patients. Several more are in late-stage trials. This post is a realistic assessment of where CRISPR works, where it doesn't, and what the remaining obstacles are — including off-target editing, in vivo delivery, and the $2.2M price tag. → [Full clinical status breakdown](/node/1177)
// COMMENTS
Newest First
ON THIS PAGE